Macroprolactinoma with secondary resistance to dopamine agonists: a case report and review of the literature 

BACKGROUND: Resistance to dopamine agonists is not uncommonly seen in prolactinomas. However, development of resistance to dopamine agonists after an initial period of robust treatment response is rare, and only 39 cases have been reported in the past four decades. We describe a Chinese man with thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Tng, Eng-Loon, Teo, Ada Ee Der, Aung, Aye Thida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021939/
https://www.ncbi.nlm.nih.gov/pubmed/36927797
http://dx.doi.org/10.1186/s13256-023-03820-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021939/
https://www.ncbi.nlm.nih.gov/pubmed/36927797
http://dx.doi.org/10.1186/s13256-023-03820-5

Ejemplares similares